Davidson Ebru — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Davidson Ebru has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Public SEC filings indicate that Davidson Ebru serves as a director of Kazia Therapeutics Limited as of the most recent filing dated 2026-07-08. There is limited publicly available biographical information about this individual beyond the director role; no independent confirmation of prior positions or background is readily available in major biographical sources. Name variations such as 'Ebru Davidson' or 'Dr. Ebru Davidson' may appear in different contexts; based on the SEC filing, the role identified is Director for Kazia Therapeutics Limited, an Australian clinical-stage biotechnology company.
Role
Director
Notability
25/100
Board memberships
Kazia Therapeutics Limited
Awards & honors
Director of Kazia Therapeutics Limited as of 2026-07-08
Public SEC filings indicate that Davidson Ebru serves as a director of Kazia Therapeutics Limited as of the most recent filing dated 2026-07-08. There is limited publicly available biographical information about this individual beyond the director role; no independent confirmation of prior positions or background is readily available in major biographical sources. Name variatio…
How many SEC Form 4 filings has Davidson Ebru submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Davidson Ebru's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
